By harnessing our cutting-edge technologies, we achieve a remarkable 70% to 90% reduction in processing and analysis times for healthcare data. We seamlessly integrate trial data with patient records, medical histories, and adverse event data, yielding more precise trial insights. This scalability not only slashes operating expenses but also boosts return on investment.
Our expert team utilizes platform-specific APIs, crawlers, and an array of tools to gather data efficiently. To weed out false or non-useful warnings, our dedicated data engineers and specialists apply stringent company standards and inclusion/exclusion logic to parsed data. We implement universal standardization to ensure no duplicate warnings.
Our data extractors' performance undergoes constant evaluation through rigorous quality dashboards. As a result, SG Analytics continues to be the preferred partner for healthcare and life sciences organizations across the Americas and Europe, delivering unparalleled data-driven solutions.
For a medication trial to be successful, researchers need access to high-quality data promptly so they may make informed decisions that will improve patient outcomes. In terms of platform management, SGA is unparalleled.
As the 'go-to solution' supplier, we are the experts in the fields of patent data, drug and med-tech protection, tracking related patents, and having access to significant patent registers and regulatory organizations.
We provide you and your team with a specialized, white-labeled, machine learning (ML)-enabled market study solution with exclusive first access to data.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships)
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine and...
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
CASE STUDIES
